Literature DB >> 15342949

STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells.

Tomoyuki Sumi1, Yasuko Fujimoto, Norio Nakatsuji, Hirofumi Suemori.   

Abstract

The leukemia inhibitory factor (LIF)/glycoprotein 130 (gp130)/signal transducer and activator of transcription 3 (STAT3) pathway plays an essential role in the maintenance of self-renewal and pluripotency in mouse embryonic stem (ES) cells. However, in primate ES cells, including those from humans and monkeys, LIF alone is not sufficient to maintain self-renewal. The precise role of the LIF/gp130/STAT3 pathway for self-renewal in primate ES cells is still unclear. In this study, we found that stimulation of cynomolgus monkey ES cells with LIF or interleukin (IL)-6/soluble IL-6 receptor leads to STAT3 phosphorylation, an effect seen previously in murine ES cells. Concomitant with this notion, nuclear translocalization and transcriptional activation of STAT3 were observed in a LIF-dependent manner. Moreover, the analysis of a dominant interfering mutant, STAT3F, showed that even though the phosphorylation, nuclear translocalization, and transcriptional activation of endogenous STAT3 after LIF stimulation were completely abrogated by over-expressing STAT3F in monkey ES cells, they continued to proliferate in an undifferentiated state, retaining their pluripotency. These results demonstrate that the LIF/gp130/STAT3 pathway functions in cynomolgus monkey ES cells but is not essential for the maintenance of self-renewal. They also suggest that cynomolgus monkey ES cells, unlike murine ES cells, are maintained in an undifferentiated state through LIF/gp130/STAT3-independent signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342949     DOI: 10.1634/stemcells.22-5-861

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  14 in total

Review 1.  The pursuit of ES cell lines of domesticated ungulates.

Authors:  Neil C Talbot; Le Ann Blomberg
Journal:  Stem Cell Rev       Date:  2008-07-09       Impact factor: 5.739

2.  Human pluripotent stem cells: from biology to cell therapy.

Authors:  Jean-Marie Ramirez; Qiang Bai; Marilyne Dijon-Grinand; Said Assou; Sabine Gerbal-Chaloin; Samir Hamamah; John De Vos
Journal:  World J Stem Cells       Date:  2010-04-26       Impact factor: 5.326

3.  Low-dose curcumin stimulates proliferation of rat embryonic neural stem cells through glucocorticoid receptor and STAT3.

Authors:  Xiao-Xiao Ma; Jin Liu; Chun-Man Wang; Jiang-Ping Zhou; Zhen-Zhou He; Han Lin
Journal:  CNS Neurosci Ther       Date:  2018-03-12       Impact factor: 5.243

Review 4.  STAT3 and cardiac remodeling.

Authors:  Arash Haghikia; Britta Stapel; Melanie Hoch; Denise Hilfiker-Kleiner
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

Review 5.  Pluripotency and nuclear reprogramming.

Authors:  Shinya Yamanaka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

Review 6.  Pluripotent stem cells and their niches.

Authors:  M William Lensch; Laurence Daheron; Thorsten M Schlaeger
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 7.  Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects.

Authors:  P Fischer; D Hilfiker-Kleiner
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

8.  Role of STAT3 in Transformation and Drug Resistance in CML.

Authors:  Rajesh R Nair; Joel H Tolentino; Lori A Hazlehurst
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

9.  Molecular basis of Mammalian embryonic stem cell pluripotency and self-renewal.

Authors:  S P Medvedev; A I Shevchenko; S M Zakian
Journal:  Acta Naturae       Date:  2010-07       Impact factor: 1.845

10.  Rho-associated kinase inhibitor Y-27632 promotes survival of cynomolgus monkey embryonic stem cells.

Authors:  Toshiyuki Takehara; Takeshi Teramura; Yuta Onodera; Ryo Kakegawa; Naoto Fukunaga; Makoto Takenoshita; Norimasa Sagawa; Kanji Fukuda; Yoshihiko Hosoi
Journal:  Mol Hum Reprod       Date:  2008-10-21       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.